On August 29, 2018 Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the "Company") (OTCQB Venture Market: INNV), an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, reported that Dr. Bassam Damaj, President & Chief Executive Officer, and Ryan Selhorn, Vice President, Chief Financial Officer, will present at the 2018 H.C. Wainwright 20th Annual Global Investment Conference, on Thursday, September 6, 2018 (Press release, Innovus Pharmaceuticals, AUG 29, 2018, View Source [SID1234529122]). They will present an update on the Company’s growing revenues, the launch of new products, its path to profitability and its other business plans.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Dr. Damaj and Mr. Selhorn will be meeting with members of the investment community during one-on-one meetings at the conference as well. The corporate presentation will be available for download on the Innovus Pharma web site (www.innovuspharma.com).
About Conference Presentation Time
Event: H.C. Wainwright 20th Annual Global Investment Conference
Date: Thursday, September 6, 2018
Time: 10:25 AM-10:50 AM EDT
Location: St. Regis New York at 2 E 55th St., New York, NY 10022